|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation | |||||
| Impairment of property and equipment | |||||
| Amortization of intangible assets | |||||
| Net gains from investments | |||||
| Deferred income taxes | |||||
| Stock-based compensation | |||||
| Credit losses on note receivable | |||||
| Goodwill impairment | |||||
| Operating lease right-of-use assets amortization and impairments | |||||
| Amortization of deferred financing fees | |||||
| Amortization of premium (discount) on investments | |||||
| Foreign currency losses | |||||
| Loss from sale of divested operation | |||||
| Other, net | |||||
| Changes in assets and liabilities | |||||
| Accounts receivable | |||||
| Deferred commissions | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable investments | |||||
| Proceeds from maturities of marketable investments | |||||
| Proceeds from sales of marketable investments | |||||
| Proceeds from sale of divested operation | |||||
| Other investing activity | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Payments on borrowings | |||||
| Payment of debt issuance costs | |||||
| Repurchases of common stock | |||||
| Proceeds from issuance of common stock under employee equity incentive plans | |||||
| Taxes paid for net share settlements of stock-based compensation awards | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-cash transactions: | |||||
| Additions to property, plant and equipment included in accounts payable and accrued expenses | |||||
Loading...